Molecular hydrogen potentiates beneficial anti-infarct effect of hypoxic postconditioning in isolated rat hearts: a novel cardioprotective intervention.
Marek Zálešák, Branislav Kura, Ján Graban, Veronika Farkašová, Ján Slezák, Tatiana Ravingerová · Canadian journal of physiology and pharmacology · 2017
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, H₂ present in KHB during HPostC further decreased IS/AR compared with the effect of HPostC, attenuated severe arrhythmias, and significantly restored heart function (vs. controls). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. H₂ present in KHB during HPostC further decreased IS/AR compared with the effect of HPostC, attenuated severe arrhythmias, and significantly restored heart function (vs. controls).
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Hydrogen treatment may have a potential to be applied in a clinical practice to improve prognosis of the patients in reconvalescence after infarction or larger cardiosu rgical interventions using heartPlung apparatus as well as after heart transplantation. H₂ present in KHB during HPostC further decreased IS/AR compared with the effect of HPostC, attenuated severe arrhythmias, and significantly restored heart function (vs. controls). The authors concluded that these results indicate that hydrogen treatment may have a potential to enhance the effectivity of prosurvival maneuvers, such as HpostC, and as a sel ective antioxidant, to preserve NO• Page 13 of 27 https://mc06.manuscriptcentral.com/cjpp-pubs Canadian Journal of Physiology and Pharmacology Draft 14 production important for dilatation of coronary art eries and recovery of coronary flow.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment.
Limitations and Safety
Reported limitations: However, the major limitation concerning cli nical application of IP emerges from the fact that protection provided by IP is a relatively shortPlived phenomenon.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://utoronto.scholaris.ca/server/api/core/bitstreams/3c5c396b-38a6-4953-984a-2dbac82bc614/content.